Indicated for: allergic rhinitis; urticaria
Substance: naphazoline + chlorpheniramine maleate (adrenergic decongestant + antiallergic agent)
ATC: S01GA51 (Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants)
The combination of Naphazolinum + Chlorpheniramine Maleate is used for the symptomatic treatment of allergic rhinitis and nasal congestion. It combines the decongestant effect of Naphazolinum with the antihistamine properties of chlorpheniramine, providing rapid symptom relief.
The medication is available as nasal drops and is effective in reducing inflammation, congestion, and nasal itching. It is intended for short-term use, typically no more than 5-7 days.
Side effects may include dryness of the nasal mucosa, drowsiness, or local irritation. Prolonged use may lead to rebound congestion or other complications.
Consult your doctor before use, especially if you have chronic conditions or are taking other medications. Follow the recommended dosage to avoid side effects.